Here's Why Adaptive Biotechnologies Soared 61.7% in the First Half of 2020
Shares of Adaptive Biotechnologies (NASDAQ: ADPT) rose over 61% in the first six months of the year, according to data provided by S&P Global Market Intelligence. That was easily better than the 4% decline of the S&P 500 in that span.
The stock had been mired in a near-continuous slide from its initial public offering last summer through this March, but that changed when the company pledged to throw its technology platform at the coronavirus pandemic. Can the growth stock continue its momentum in the second half of 2020?
Image source: Getty Images.
Source Fool.com
